VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $2,119,000 | -47.7% | 20,845 | -8.3% | 4.56% | -55.5% |
| Q3 2015 | $4,053,000 | -10.4% | 22,720 | +11.5% | 10.25% | -8.6% |
| Q2 2015 | $4,525,000 | +11.6% | 20,370 | -0.2% | 11.22% | +0.1% |
| Q1 2015 | $4,056,000 | +29.6% | 20,420 | -6.6% | 11.21% | +20.4% |
| Q4 2014 | $3,129,000 | +18.9% | 21,866 | +7.2% | 9.31% | +21.4% |
| Q3 2014 | $2,631,000 | -46.8% | 20,399 | -49.8% | 7.67% | +11.3% |
| Q2 2014 | $4,947,000 | +85.5% | 40,627 | +100.8% | 6.89% | -14.9% |
| Q1 2014 | $2,667,000 | +12.0% | 20,230 | -0.3% | 8.10% | +15.5% |
| Q4 2013 | $2,382,000 | +13.3% | 20,293 | +0.7% | 7.01% | -3.1% |
| Q3 2013 | $2,103,000 | +30.8% | 20,157 | +7.9% | 7.24% | +26.1% |
| Q2 2013 | $1,608,000 | – | 18,684 | – | 5.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |